LRRF2_HUMAN - dbPTM
LRRF2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LRRF2_HUMAN
UniProt AC Q9Y608
Protein Name Leucine-rich repeat flightless-interacting protein 2
Gene Name LRRFIP2
Organism Homo sapiens (Human).
Sequence Length 721
Subcellular Localization
Protein Description May function as activator of the canonical Wnt signaling pathway, in association with DVL3, upstream of CTNNB1/beta-catenin. Positively regulates Toll-like receptor (TLR) signaling in response to agonist probably by competing with the negative FLII regulator for MYD88-binding..
Protein Sequence MGTPASGRKRTPVKDRFSAEDEALSNIAREAEARLAAKRAARAEARDIRMRELERQQKEYSLHSFDRKWGQIQKWLEDSERARYSHRSSHHRPYLGVEDALSIRSVGSHRYDMFKDRSSRLSSLNHSYSHSHGMKKRSSDSHKDLLSGLYFDQRNYSSLRHSKPTSAYYTRQSSSLYSDPLATYKSDRASPTANSGLLRSASLASLYNGGLYNPYGPRTPSECSYYSSRISSARSSPGFTNDDTASIVSSDRASRGRRESVVSAADYFSRSNRRGSVVSEVDDISIPDLSSLDEKSDKQYAENYTRPSSRNSASATTPLSGNSSRRGSGDTSSLIDPDTSLSELRDIYDLKDQIQDVEGRYMQGLKELKESLSEVEEKYKKAMVSNAQLDNEKNNLIYQVDTLKDVIEEQEEQMAEFYRENEEKSKELERQKHMCSVLQHKMEELKEGLRQRDELIEEKQRMQQKIDTMTKEVFDLQETLLWKDKKIGALEKQKEYIACLRNERDMLREELADLQETVKTGEKHGLVIIPDGTPNGDVSHEPVAGAITVVSQEAAQVLESAGEGPLDVRLRKLAGEKEELLSQIRKLKLQLEEERQKCSRNDGTVGDLAGLQNGSDLQFIEMQRDANRQISEYKFKLSKAEQDITTLEQSISRLEGQVLRYKTAAENAEKVEDELKAEKRKLQRELRTALDKIEEMEMTNSHLAKRLEKMKANRTALLAQQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MGTPASGRKR
-----CCCCCCCCCC
17.8725367160
8MethylationMGTPASGRKRTPVKD
CCCCCCCCCCCCCCC
23.84115389599
11PhosphorylationPASGRKRTPVKDRFS
CCCCCCCCCCCCCCC
35.1526074081
18PhosphorylationTPVKDRFSAEDEALS
CCCCCCCCHHHHHHH
31.4830266825
25PhosphorylationSAEDEALSNIAREAE
CHHHHHHHHHHHHHH
32.9823403867
80PhosphorylationQKWLEDSERARYSHR
HHHHHHHHHHHHCCC
63.7833259812
85PhosphorylationDSERARYSHRSSHHR
HHHHHHHCCCCCCCC
13.5826074081
88PhosphorylationRARYSHRSSHHRPYL
HHHHCCCCCCCCCCC
28.7119664995
89PhosphorylationARYSHRSSHHRPYLG
HHHCCCCCCCCCCCC
24.2226074081
96PhosphorylationSHHRPYLGVEDALSI
CCCCCCCCHHHCCCC
18.2232142685
96 (in isoform 2)Phosphorylation-18.2222617229
99 (in isoform 2)Phosphorylation-50.8622199227
100 (in isoform 2)Phosphorylation-6.9522199227
101 (in isoform 2)Phosphorylation-7.2722199227
102PhosphorylationLGVEDALSIRSVGSH
CCHHHCCCCCCCCCC
20.0626437602
107 (in isoform 2)Phosphorylation-20.9818669648
108PhosphorylationLSIRSVGSHRYDMFK
CCCCCCCCCCCHHCC
11.5725690035
108 (in isoform 2)Phosphorylation-11.5725159151
110 (in isoform 2)Phosphorylation-30.7421406692
111PhosphorylationRSVGSHRYDMFKDRS
CCCCCCCCHHCCCCH
13.31-
114PhosphorylationGSHRYDMFKDRSSRL
CCCCCHHCCCCHHHH
7.3233259812
115 (in isoform 2)Phosphorylation-45.6621406692
117 (in isoform 2)Phosphorylation-36.8021406692
118PhosphorylationYDMFKDRSSRLSSLN
CHHCCCCHHHHHHCC
29.9130576142
119UbiquitinationDMFKDRSSRLSSLNH
HHCCCCHHHHHHCCC
37.8324816145
122PhosphorylationKDRSSRLSSLNHSYS
CCCHHHHHHCCCCCH
31.5027134283
123PhosphorylationDRSSRLSSLNHSYSH
CCHHHHHHCCCCCHH
37.4727134283
128PhosphorylationLSSLNHSYSHSHGMK
HHHCCCCCHHCCCCC
11.67-
129PhosphorylationSSLNHSYSHSHGMKK
HHCCCCCHHCCCCCC
22.8730576142
130PhosphorylationSLNHSYSHSHGMKKR
HCCCCCHHCCCCCCC
18.6432142685
134UbiquitinationSYSHSHGMKKRSSDS
CCHHCCCCCCCCCCC
3.7624816145
149UbiquitinationHKDLLSGLYFDQRNY
HHHHHHHHHCCCCCH
3.2829967540
152PhosphorylationLLSGLYFDQRNYSSL
HHHHHHCCCCCHHHH
32.7333259812
153UbiquitinationLSGLYFDQRNYSSLR
HHHHHCCCCCHHHHC
26.1424816145
160PhosphorylationQRNYSSLRHSKPTSA
CCCHHHHCCCCCCCC
33.7032645325
168PhosphorylationHSKPTSAYYTRQSSS
CCCCCCCCEECCCCC
12.7230576142
168 (in isoform 5)Phosphorylation-12.7222617229
169PhosphorylationSKPTSAYYTRQSSSL
CCCCCCCEECCCCCC
8.6530576142
170UbiquitinationKPTSAYYTRQSSSLY
CCCCCCEECCCCCCC
15.0024816145
171 (in isoform 5)Phosphorylation-20.4722199227
172PhosphorylationTSAYYTRQSSSLYSD
CCCCEECCCCCCCCC
39.6133259812
172 (in isoform 5)Phosphorylation-39.6122199227
173PhosphorylationSAYYTRQSSSLYSDP
CCCEECCCCCCCCCC
20.7122673903
173 (in isoform 5)Phosphorylation-20.7122199227
174PhosphorylationAYYTRQSSSLYSDPL
CCEECCCCCCCCCCC
18.9422673903
175PhosphorylationYYTRQSSSLYSDPLA
CEECCCCCCCCCCCC
36.2522673903
177PhosphorylationTRQSSSLYSDPLATY
ECCCCCCCCCCCCCC
16.9924043423
178PhosphorylationRQSSSLYSDPLATYK
CCCCCCCCCCCCCCC
37.7422673903
179 (in isoform 5)Phosphorylation-28.7718669648
180PhosphorylationSSSLYSDPLATYKSD
CCCCCCCCCCCCCCC
20.2532645325
180 (in isoform 5)Phosphorylation-20.2525159151
182 (in isoform 5)Phosphorylation-17.8021406692
183PhosphorylationLYSDPLATYKSDRAS
CCCCCCCCCCCCCCC
38.8822673903
184PhosphorylationYSDPLATYKSDRASP
CCCCCCCCCCCCCCC
11.6824043423
186PhosphorylationDPLATYKSDRASPTA
CCCCCCCCCCCCCCC
23.1626437602
187 (in isoform 5)Phosphorylation-46.1121406692
188PhosphorylationLATYKSDRASPTANS
CCCCCCCCCCCCCCC
44.0232142685
189 (in isoform 5)Phosphorylation-25.5021406692
190PhosphorylationTYKSDRASPTANSGL
CCCCCCCCCCCCCHH
24.5521220426
200PhosphorylationANSGLLRSASLASLY
CCCHHHHHHHHHHHH
23.3721220426
202PhosphorylationSGLLRSASLASLYNG
CHHHHHHHHHHHHCC
26.2221220426
205PhosphorylationLRSASLASLYNGGLY
HHHHHHHHHHCCCCC
36.3621220426
207UbiquitinationSASLASLYNGGLYNP
HHHHHHHHCCCCCCC
14.8524816145
219PhosphorylationYNPYGPRTPSECSYY
CCCCCCCCHHHHHCH
34.01-
225PhosphorylationRTPSECSYYSSRISS
CCHHHHHCHHHCCCC
21.01-
231PhosphorylationSYYSSRISSARSSPG
HCHHHCCCCCCCCCC
19.4820044836
232PhosphorylationYYSSRISSARSSPGF
CHHHCCCCCCCCCCC
25.9020044836
235PhosphorylationSRISSARSSPGFTND
HCCCCCCCCCCCCCC
40.37-
236PhosphorylationRISSARSSPGFTNDD
CCCCCCCCCCCCCCC
24.4020044836
244PhosphorylationPGFTNDDTASIVSSD
CCCCCCCCHHHHCCC
25.7630387612
246PhosphorylationFTNDDTASIVSSDRA
CCCCCCHHHHCCCCH
26.1430387612
249PhosphorylationDDTASIVSSDRASRG
CCCHHHHCCCCHHCC
25.5030576142
250PhosphorylationDTASIVSSDRASRGR
CCHHHHCCCCHHCCC
21.88-
256UbiquitinationSSDRASRGRRESVVS
CCCCHHCCCHHHHHH
30.4224816145
260PhosphorylationASRGRRESVVSAADY
HHCCCHHHHHHHHHH
26.4726437602
263PhosphorylationGRRESVVSAADYFSR
CCHHHHHHHHHHHHC
18.6422673903
264UbiquitinationRRESVVSAADYFSRS
CHHHHHHHHHHHHCC
7.8624816145
266PhosphorylationESVVSAADYFSRSNR
HHHHHHHHHHHCCCC
44.7333259812
267PhosphorylationSVVSAADYFSRSNRR
HHHHHHHHHHCCCCC
9.95-
271UbiquitinationAADYFSRSNRRGSVV
HHHHHHCCCCCCCCE
33.2324816145
274PhosphorylationYFSRSNRRGSVVSEV
HHHCCCCCCCCEEEE
46.0932645325
276PhosphorylationSRSNRRGSVVSEVDD
HCCCCCCCCEEEECC
19.9626699800
279PhosphorylationNRRGSVVSEVDDISI
CCCCCCEEEECCCCC
29.7326699800
279UbiquitinationNRRGSVVSEVDDISI
CCCCCCEEEECCCCC
29.7324816145
280UbiquitinationRRGSVVSEVDDISIP
CCCCCEEEECCCCCC
38.0524816145
282PhosphorylationGSVVSEVDDISIPDL
CCCEEEECCCCCCCH
43.4032142685
285PhosphorylationVSEVDDISIPDLSSL
EEEECCCCCCCHHHC
34.7530576142
290UbiquitinationDISIPDLSSLDEKSD
CCCCCCHHHCCHHHH
35.9124816145
291PhosphorylationISIPDLSSLDEKSDK
CCCCCHHHCCHHHHH
47.3324719451
296PhosphorylationLSSLDEKSDKQYAEN
HHHCCHHHHHHHHHH
48.2528796482
298UbiquitinationSLDEKSDKQYAENYT
HCCHHHHHHHHHHCC
52.9124816145
300PhosphorylationDEKSDKQYAENYTRP
CHHHHHHHHHHCCCC
22.9421945579
300UbiquitinationDEKSDKQYAENYTRP
CHHHHHHHHHHCCCC
22.9424816145
304PhosphorylationDKQYAENYTRPSSRN
HHHHHHHCCCCCCCC
8.8121945579
305PhosphorylationKQYAENYTRPSSRNS
HHHHHHCCCCCCCCC
47.9221945579
308PhosphorylationAENYTRPSSRNSASA
HHHCCCCCCCCCCCC
38.3421945579
309PhosphorylationENYTRPSSRNSASAT
HHCCCCCCCCCCCCC
37.8621945579
311UbiquitinationYTRPSSRNSASATTP
CCCCCCCCCCCCCCC
43.8224816145
312PhosphorylationTRPSSRNSASATTPL
CCCCCCCCCCCCCCC
23.6120044836
314PhosphorylationPSSRNSASATTPLSG
CCCCCCCCCCCCCCC
26.4330266825
314UbiquitinationPSSRNSASATTPLSG
CCCCCCCCCCCCCCC
26.4324816145
315UbiquitinationSSRNSASATTPLSGN
CCCCCCCCCCCCCCC
18.4024816145
316PhosphorylationSRNSASATTPLSGNS
CCCCCCCCCCCCCCC
26.8430266825
317PhosphorylationRNSASATTPLSGNSS
CCCCCCCCCCCCCCC
23.1929255136
320PhosphorylationASATTPLSGNSSRRG
CCCCCCCCCCCCCCC
36.8129255136
320UbiquitinationASATTPLSGNSSRRG
CCCCCCCCCCCCCCC
36.8124816145
321UbiquitinationSATTPLSGNSSRRGS
CCCCCCCCCCCCCCC
45.8024816145
323PhosphorylationTTPLSGNSSRRGSGD
CCCCCCCCCCCCCCC
28.8429255136
324PhosphorylationTPLSGNSSRRGSGDT
CCCCCCCCCCCCCCH
29.9629255136
324UbiquitinationTPLSGNSSRRGSGDT
CCCCCCCCCCCCCCH
29.9624816145
326MethylationLSGNSSRRGSGDTSS
CCCCCCCCCCCCHHH
45.65115482331
328PhosphorylationGNSSRRGSGDTSSLI
CCCCCCCCCCHHHCC
31.5129255136
331PhosphorylationSRRGSGDTSSLIDPD
CCCCCCCHHHCCCCC
24.6022167270
332PhosphorylationRRGSGDTSSLIDPDT
CCCCCCHHHCCCCCC
28.0822167270
333PhosphorylationRGSGDTSSLIDPDTS
CCCCCHHHCCCCCCC
31.2822167270
334UbiquitinationGSGDTSSLIDPDTSL
CCCCHHHCCCCCCCH
5.2924816145
335UbiquitinationSGDTSSLIDPDTSLS
CCCHHHCCCCCCCHH
8.5824816145
336UbiquitinationGDTSSLIDPDTSLSE
CCHHHCCCCCCCHHH
40.0724816145
337UbiquitinationDTSSLIDPDTSLSEL
CHHHCCCCCCCHHHH
39.5224816145
339PhosphorylationSSLIDPDTSLSELRD
HHCCCCCCCHHHHHH
36.6330266825
340PhosphorylationSLIDPDTSLSELRDI
HCCCCCCCHHHHHHH
36.9630266825
342PhosphorylationIDPDTSLSELRDIYD
CCCCCCHHHHHHHHC
34.0630266825
345UbiquitinationDTSLSELRDIYDLKD
CCCHHHHHHHHCHHH
24.9924816145
348PhosphorylationLSELRDIYDLKDQIQ
HHHHHHHHCHHHHHH
21.3623403867
348UbiquitinationLSELRDIYDLKDQIQ
HHHHHHHHCHHHHHH
21.3624816145
350UbiquitinationELRDIYDLKDQIQDV
HHHHHHCHHHHHHHH
3.5524816145
351UbiquitinationLRDIYDLKDQIQDVE
HHHHHCHHHHHHHHH
44.6924816145
355UbiquitinationYDLKDQIQDVEGRYM
HCHHHHHHHHHHHHH
42.9624816145
359UbiquitinationDQIQDVEGRYMQGLK
HHHHHHHHHHHHHHH
26.3524816145
360UbiquitinationQIQDVEGRYMQGLKE
HHHHHHHHHHHHHHH
15.3924816145
365UbiquitinationEGRYMQGLKELKESL
HHHHHHHHHHHHHHH
1.8824816145
370UbiquitinationQGLKELKESLSEVEE
HHHHHHHHHHHHHHH
70.3224816145
379UbiquitinationLSEVEEKYKKAMVSN
HHHHHHHHHHHHHHH
22.4724816145
381UbiquitinationEVEEKYKKAMVSNAQ
HHHHHHHHHHHHHHC
38.3329967540
383SulfoxidationEEKYKKAMVSNAQLD
HHHHHHHHHHHHCCC
4.6930846556
389UbiquitinationAMVSNAQLDNEKNNL
HHHHHHCCCCCCCCC
7.6924816145
396UbiquitinationLDNEKNNLIYQVDTL
CCCCCCCCEEEHHHH
5.5824816145
398PhosphorylationNEKNNLIYQVDTLKD
CCCCCCEEEHHHHHH
12.9725159151
410UbiquitinationLKDVIEEQEEQMAEF
HHHHHHHHHHHHHHH
46.8924816145
413UbiquitinationVIEEQEEQMAEFYRE
HHHHHHHHHHHHHHH
35.3224816145
420UbiquitinationQMAEFYRENEEKSKE
HHHHHHHHCHHHHHH
58.5824816145
423UbiquitinationEFYRENEEKSKELER
HHHHHCHHHHHHHHH
74.3724816145
433UbiquitinationKELERQKHMCSVLQH
HHHHHHHHHHHHHHH
17.7224816145
444UbiquitinationVLQHKMEELKEGLRQ
HHHHHHHHHHHHHHH
62.7424816145
447UbiquitinationHKMEELKEGLRQRDE
HHHHHHHHHHHHHHH
75.8824816145
454UbiquitinationEGLRQRDELIEEKQR
HHHHHHHHHHHHHHH
54.5624816145
458UbiquitinationQRDELIEEKQRMQQK
HHHHHHHHHHHHHHH
47.7124816145
459UbiquitinationRDELIEEKQRMQQKI
HHHHHHHHHHHHHHH
30.3424816145
464UbiquitinationEEKQRMQQKIDTMTK
HHHHHHHHHHHHHHH
35.0224816145
468O-linked_GlycosylationRMQQKIDTMTKEVFD
HHHHHHHHHHHHHHH
30.1630379171
468PhosphorylationRMQQKIDTMTKEVFD
HHHHHHHHHHHHHHH
30.1620068231
470PhosphorylationQQKIDTMTKEVFDLQ
HHHHHHHHHHHHHHH
26.5830206219
476UbiquitinationMTKEVFDLQETLLWK
HHHHHHHHHHHHHHC
3.1724816145
478UbiquitinationKEVFDLQETLLWKDK
HHHHHHHHHHHHCCC
49.0424816145
479PhosphorylationEVFDLQETLLWKDKK
HHHHHHHHHHHCCCC
17.7530206219
488UbiquitinationLWKDKKIGALEKQKE
HHCCCCCCHHHHHHH
32.7524816145
490UbiquitinationKDKKIGALEKQKEYI
CCCCCCHHHHHHHHH
7.7224816145
495UbiquitinationGALEKQKEYIACLRN
CHHHHHHHHHHHHHC
39.4124816145
505UbiquitinationACLRNERDMLREELA
HHHHCHHHHHHHHHH
34.0024816145
512UbiquitinationDMLREELADLQETVK
HHHHHHHHHHHHHHH
20.8124816145
522UbiquitinationQETVKTGEKHGLVII
HHHHHCCCCCCEEEE
47.3024816145
524UbiquitinationTVKTGEKHGLVIIPD
HHHCCCCCCEEEECC
30.4324816145
526UbiquitinationKTGEKHGLVIIPDGT
HCCCCCCEEEECCCC
2.2124816145
532UbiquitinationGLVIIPDGTPNGDVS
CEEEECCCCCCCCCC
37.4024816145
541UbiquitinationPNGDVSHEPVAGAIT
CCCCCCCCCCCCEEE
33.6824816145
546UbiquitinationSHEPVAGAITVVSQE
CCCCCCCEEEEECHH
5.6424816145
547UbiquitinationHEPVAGAITVVSQEA
CCCCCCEEEEECHHH
2.6924816145
551PhosphorylationAGAITVVSQEAAQVL
CCEEEEECHHHHHHH
20.2629496963
553UbiquitinationAITVVSQEAAQVLES
EEEEECHHHHHHHHH
38.1724816145
560UbiquitinationEAAQVLESAGEGPLD
HHHHHHHHCCCCCHH
37.1024816145
561UbiquitinationAAQVLESAGEGPLDV
HHHHHHHCCCCCHHH
15.6424816145
562UbiquitinationAQVLESAGEGPLDVR
HHHHHHCCCCCHHHH
50.0724816145
563UbiquitinationQVLESAGEGPLDVRL
HHHHHCCCCCHHHHH
58.3024816145
575UbiquitinationVRLRKLAGEKEELLS
HHHHHHHCCHHHHHH
57.8724816145
576UbiquitinationRLRKLAGEKEELLSQ
HHHHHHCCHHHHHHH
52.2524816145
5772-HydroxyisobutyrylationLRKLAGEKEELLSQI
HHHHHCCHHHHHHHH
56.42-
577AcetylationLRKLAGEKEELLSQI
HHHHHCCHHHHHHHH
56.4226051181
577UbiquitinationLRKLAGEKEELLSQI
HHHHHCCHHHHHHHH
56.4224816145
587UbiquitinationLLSQIRKLKLQLEEE
HHHHHHHHHHHHHHH
4.8724816145
589UbiquitinationSQIRKLKLQLEEERQ
HHHHHHHHHHHHHHH
11.5724816145
604UbiquitinationKCSRNDGTVGDLAGL
HHHCCCCCHHHHHHC
24.9524816145
611UbiquitinationTVGDLAGLQNGSDLQ
CHHHHHHCCCCCCCC
2.7324816145
615PhosphorylationLAGLQNGSDLQFIEM
HHHCCCCCCCCCEEH
42.5727251275
621UbiquitinationGSDLQFIEMQRDANR
CCCCCCEEHHHHHHH
30.4724816145
623UbiquitinationDLQFIEMQRDANRQI
CCCCEEHHHHHHHHH
27.5824816145
625UbiquitinationQFIEMQRDANRQISE
CCEEHHHHHHHHHHH
31.1624816145
638PhosphorylationSEYKFKLSKAEQDIT
HHHHHHHCHHHHHHH
30.3425247763
640UbiquitinationYKFKLSKAEQDITTL
HHHHHCHHHHHHHHH
19.1224816145
645UbiquitinationSKAEQDITTLEQSIS
CHHHHHHHHHHHHHH
33.3524816145
646UbiquitinationKAEQDITTLEQSISR
HHHHHHHHHHHHHHH
28.7324816145
652PhosphorylationTTLEQSISRLEGQVL
HHHHHHHHHHHHHHH
35.7425247763
652UbiquitinationTTLEQSISRLEGQVL
HHHHHHHHHHHHHHH
35.7424816145
659UbiquitinationSRLEGQVLRYKTAAE
HHHHHHHHHHHHHHH
3.6824816145
660UbiquitinationRLEGQVLRYKTAAEN
HHHHHHHHHHHHHHH
31.8524816145
661UbiquitinationLEGQVLRYKTAAENA
HHHHHHHHHHHHHHH
14.4524816145
662UbiquitinationEGQVLRYKTAAENAE
HHHHHHHHHHHHHHH
25.8324816145
675UbiquitinationAEKVEDELKAEKRKL
HHHHHHHHHHHHHHH
11.1624816145
676UbiquitinationEKVEDELKAEKRKLQ
HHHHHHHHHHHHHHH
53.0724816145
699PhosphorylationKIEEMEMTNSHLAKR
HHHHHHHHHHHHHHH
21.9128270605
701PhosphorylationEEMEMTNSHLAKRLE
HHHHHHHHHHHHHHH
15.6528270605
715PhosphorylationEKMKANRTALLAQQ-
HHHHHHHHHHHHCC-
22.8228555341

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of LRRF2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
190SPhosphorylation

21220426
202SPhosphorylation

21220426
202SPhosphorylation

21220426

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LRRF2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FLII_HUMANFLIIphysical
19265123
ATPF2_HUMANATPAF2physical
25416956
CAZA1_HUMANCAPZA1physical
26344197
FLII_HUMANFLIIphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LRRF2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320; SER-324 ANDSER-328, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320; SER-323 ANDSER-324, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY.
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction.";
Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
Mol. Cell. Proteomics 6:1952-1967(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY.
"Unambiguous characterization of site-specific phosphorylation ofleucine-rich repeat Fli-I-interacting protein 2 (LRRFIP2) in Toll-likereceptor 4 (TLR4)-mediated signaling.";
Gunawardena H.P., Huang Y., Kenjale R., Wang H., Xie L., Chen X.;
J. Biol. Chem. 286:10897-10910(2011).
Cited for: PROTEIN SEQUENCE OF 186-218 AND 326-345, PHOSPHORYLATION AT SER-190AND SER-202, MUTAGENESIS OF SER-190; SER-200 AND SER-202, AND MASSSPECTROMETRY.

TOP